Author:
Gao Xinbo,Guo Kai,Santosa Samuel M.,Montana Mario,Yamakawa Michael,Hallak Joelle A.,Han Kyu-Yeon,Doh Susan J.,Rosenblatt Mark I.,Chang Jin-Hong,Azar Dimitri T.
Funder
U.S. Department of Health & Human Services | NIH | Center for Scientific Review
Center for Integrated Healthcare, U.S. Department of Veterans Affairs
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Ellenberg, D. et al. Novel aspects of corneal angiogenic and lymphangiogenic privilege. Progress in retinal and eye research 29, 208–248,
https://doi.org/10.1016/j.preteyeres.2010.01.002
(2010).
2. Chen, L. et al. AP-2beta Is a Downstream Effector of PITX2 Required to Specify Endothelium and Establish Angiogenic Privilege During Corneal Development. Investigative ophthalmology & visual science 57, 1072–1081,
https://doi.org/10.1167/iovs.15-18103
(2016).
3. Azar, D. T. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Transactions of the American Ophthalmological Society 104, 264–302 (2006).
4. Zhong, W. et al. Angiogenesis and lymphangiogenesis in corneal transplantation-A review. Survey of ophthalmology,
https://doi.org/10.1016/j.survophthal.2017.12.008
(2017).
5. Chang, J. H., Gabison, E. E., Kato, T. & Azar, D. T. Corneal neovascularization. Current opinion in ophthalmology 12, 242–249 (2001).
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献